TRIOFAN Antitussif Noscapine cpr 20 pce

7680688110012 CH-68811 R05DA07 03.01.2.
TRIOFAN Antitussif Noscapine cpr 20 pce
TRIOFAN Antitussif Noscapine cpr 20 pce
TRIOFAN Antitussif Noscapine cpr 20 pce
1 / 3
google

Details

Product number
6881101
CPT
-
Packaging group
20
Unit
Tablette(n)
Composition
noscapini hydrochloridum hydricum 15 mg corresp. noscapinum 13.25 mg, lactosum monohydricum 80.707 mg, maydis amylum, amylum pregelificatum, talcum, magnesii stearas, pellicule: saccharum 64.826 mg, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, silica colloidalis anhydrica, talcum, calcii carbonas, carmellosum natricum, macrogolum 6000, natrii docusas, glucosum 2.15 mg, povidonum K 25, E 171, natrii benzoas 0.008 mg, E 132, lacca, cera alba, cera carnauba, pro compresso obducto corresp. natrium max. 0.06 mg.

Articles (1)

Triofan Antitussif Noscapine, comprimés enrobés
Tabletten
20
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/11/2023
Patient information leaflet
Français
09/11/2023
Patient information leaflet
Italien
09/11/2023
Professional SmPC
Allemand
09/11/2023
Professional SmPC
Français
09/11/2023
Professional SmPC
Italien
09/11/2023

Detailed composition

Substance Quantity Type Category
(N/A)
15.0 MG Substance Wirkstoff (Principe actif)
(N/A)
13.25 MG Substance WIIS
(N/A)
80.707 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
64.826 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
2.15 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
0.008 MG Substance HBESI
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Authorization holder

Verfora SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
68811
Drug name
Triofan Antitussif Noscapine, comprimés enrobés
Galenic form
UEBT
ATC Code
R05DA07
Authorization status
Z
Dispensation category
D
First authorization
08/05/2023
Authorization expiration date
07/05/2028
IT number
03.01.2.
Domain
Human medicine

Packaging details

Description (FR)
TRIOFAN Antitussif Noscapine cpr 20 pce
Description (DE)
TRIOFAN Hustenstiller Noscapin Tabl 20 Stk
Market launch
08/05/2023
Narcotic (BTM)
No